ARCHIVES

Rituximab and Fludarabine Combination Produces Long-Term Remissions in CLL

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

September 29, 2006

New Algorithm Completes Scan Three Times Faster Than Before

November 25, 2011

In Brief: AACR, ASCO Meeting In Toronto; Regional Planners Threaten Cancer Program Delays

April 9, 1976

Cancer Cases To Double By 2050, Annual Report Says

May 31, 2002

Former Group Chair Responds To Niederhuber: Change But Don’t Dissolve Cooperative Groups

July 2, 2010

“We Will Move Forward With Bold Expectations,” NCI Director Says

October 2, 1998